Ignite Creation Date:
2025-12-18 @ 8:13 AM
Ignite Modification Date:
2025-12-23 @ 6:57 PM
Study NCT ID:
NCT07198724
Status:
Last Update Posted:
First Post:
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer
Sponsor:
Organization: